Kumar Amit

Chief Executive Officer, DirectorAnixa Biosciences Inc (ANIX) · full profile →Form 4 · filed Jul 31, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$42K
Net Open-Market Flow
-$42K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 31, 2023Sell(S)12K$3.57$42K462K
Jul 28, 2023Option exercise(M)40K$2.58$103K502K
Jul 28, 2023Tax withholding(F)28K$3.63$103K474K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 28, 2023Option exercise(M)40K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-026125) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ANIX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-23-026125"
Ask your agent
Use Arkolith to summarize insider buying and selling at Anixa Biosciences Inc
over the last 90 days and cite the filings.